Lakeshore Biopharma (NASDAQ:LSB) Trading Up 1.9% – Here’s Why

Lakeshore Biopharma Co., Ltd. (NASDAQ:LSB) shares shot up 1.9% during mid-day trading on Friday . The company traded as high as $2.70 and last traded at $2.62. 4,313 shares traded hands during trading, a decline of 79% from the average session volume of 20,171 shares. The stock had previously closed at $2.57.

Lakeshore Biopharma Price Performance

The business’s 50 day moving average price is $4.29. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.87 and a current ratio of 1.13.

Institutional Investors Weigh In On Lakeshore Biopharma

A number of hedge funds have recently modified their holdings of the stock. FMR LLC bought a new position in shares of Lakeshore Biopharma during the 3rd quarter worth $803,000. Hhlr Advisors LTD. purchased a new stake in Lakeshore Biopharma during the third quarter valued at about $513,000. Finally, Barclays PLC bought a new position in Lakeshore Biopharma during the third quarter worth about $169,000. Institutional investors own 52.64% of the company’s stock.

Lakeshore Biopharma Company Profile

LakeShore Biopharma Co, Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001.